Bioventus (BVS) Competitors

National Vision (NASDAQ:EYE) and Bioventus (NYSE:BVS) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Which has more risk & volatility, EYE or BVS?

National Vision has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of EYE or BVS?

62.9% of Bioventus shares are held by institutional investors. 2.7% of National Vision shares are held by company insiders. Comparatively, 33.0% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Is EYE or BVS more profitable?

National Vision has a net margin of -1.40% compared to Bioventus' net margin of -7.11%. Bioventus' return on equity of 15.61% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	-1.40%	3.44%	1.40%
Bioventus	-7.11%	15.61%	4.01%

Which has better earnings and valuation, EYE or BVS?

National Vision has higher revenue and earnings than Bioventus. National Vision is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.82B	1.10	-$28.50M	-$0.33	-76.79
Bioventus	$567.70M	0.93	-$156.23M	-$0.48	-13.33

Do analysts prefer EYE or BVS?

National Vision presently has a consensus target price of $23.00, suggesting a potential downside of 9.23%. Bioventus has a consensus target price of $13.75, suggesting a potential upside of 114.84%. Given Bioventus' stronger consensus rating and higher possible upside, analysts clearly believe Bioventus is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Does the media favor EYE or BVS?

In the previous week, National Vision had 10 more articles in the media than Bioventus. MarketBeat recorded 11 mentions for National Vision and 1 mentions for Bioventus. Bioventus' average media sentiment score of 1.68 beat National Vision's score of 1.02 indicating that Bioventus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	4 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Bioventus	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

National Vision and Bioventus tied by winning 8 of the 16 factors compared between the two stocks.